A Nigerian healthcare researcher based in the United States, Ehinomhen Inegbedion, is gaining academic recognition for research examining the ethical risks associated with the growing use of artificial intelligence in modern healthcare systems.

Inegbedion, a graduate of University of Port Harcourt, is currently pursuing a Master of Business Administration (MBA) in Healthcare Administration at Western Governors University, where her work focuses on the intersection of technology, healthcare financing, and policy.

She is a co-author of a peer-reviewed study published in the International Journal of Science and Research Archive titled “AI-Driven Healthcare Financial Models: Ethical Frameworks for Balancing Profit and Access in Precision Medicine in the US.”

The 2024 publication explores concerns that artificial intelligence systems increasingly used by hospitals, insurers, and pharmaceutical companies to guide financial and treatment decisions could widen healthcare inequality if ethical safeguards are not properly embedded.

According to the study, while precision medicine — which tailors treatment to individual patients — promises significant medical advances, algorithm-driven financial models risk limiting access to advanced care for low-income populations if profitability becomes the dominant factor in decision-making.

The researchers argue that without regulatory and ethical oversight, AI technologies designed to improve efficiency may unintentionally reinforce existing disparities within healthcare systems.

Beyond academic research, Inegbedion’s work is informed by practical healthcare experience gained while providing care to elderly and paediatric patients across healthcare and social service settings in New Jersey, United States.

Her research portfolio also includes a 2025 study on healthcare policy changes and hospital management published in the International Journal of Multidisciplinary Research and Growth Evaluation, as well as collaborative research on the development of a label-free electrochemical biosensor for early detection of neurodegenerative disease biomarkers published in the International Journal of Medical and All Body Health Research.

The studies bring together expertise spanning artificial intelligence ethics, healthcare systems management, and biomedical diagnostics — an interdisciplinary scope considered uncommon for an early-career researcher.

Her co-authors are affiliated with institutions including Georgia State University and Duke University, reflecting expanding academic collaboration across American universities.

Speaking on her research direction, Inegbedion said the future of healthcare depends on stronger links between technology, economics, and policy frameworks capable of ensuring equitable access to medical innovation.

Her growing body of work highlights the increasing role of Nigerian-trained professionals within global healthcare research, particularly in shaping debates around how emerging technologies can be deployed without excluding vulnerable populations.

With additional publications expected in 2026, Inegbedion is part of a new generation of Nigerian diaspora scholars contributing to international conversations on the future of healthcare delivery and ethical artificial intelligence.